Astrocytoma, IDH-Mutant, Grade 4 Clinical Trials

6 clinical trials for Astrocytoma, IDH-Mutant, Grade 4 across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — RECRUITING · PHASE3
• Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas — RECRUITING · PHASE1
• Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma — RECRUITING · PHASE1
• Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques — RECRUITING · NA
• A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden — ACTIVE_NOT_RECRUITING · PHASE2
• GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 — COMPLETED

Refine this search